OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.49 USD
-0.03 (-1.97%)
Updated Jul 19, 2024 04:00 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPK 1.49 -0.03(-1.97%)
Will OPK be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPK
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
Other News for OPK
Noteworthy Friday Option Activity: OPK, ABR, PCRX
What You Missed On Wall Street This Morning
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday
OPKO Health Announces $100 Million Share Repurchase Program
Opko Health announces $100M share repurchase program